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Anaphylactic reaction to Praziquantel
treatment: First case report from Yemen
A.A.T. Jaawal
Public health care, Sanaa, Yemen
Background: Praziquantel (PZQ) has been used comprehen-
sively in Yemen during recent years where more than nine million
Yemenis were treated during the May 2013 national campaign
against schistosomiasis. PZQ is safe for global use despite some
known mild transient adverse effects. However, severe reactions
have been rarely recognized. Although PZQ has been globally used
for more than a billion people during last 30 years, at present
less than 10 cases of hypersensitive reactions have been reported
worldwide. Here we report the ﬁrst case of severe anaphylactic
reaction from PZQ from Yemen
Methods & Materials: Case report
Results: A 21-year-old Yemeni previously healthy man was
administered PZQ during the last national campaign against schis-
tosomiasis. Thirty minutes later he experienced a sudden onset of
itching urticaria over his entire bodywith facial swelling, dizziness,
and syncope. The patient had no recent medication history except
for the PZQ and had no speciﬁc medical history. He was brought
in shock to the emergency department of Ibin Khldoon hospital in
Lahj where he diagnosed as having severe anaphylactic reaction
with skin eruptions induced by PZQ. His symptoms subsided two
days later after intensive anti-anaphylactic treatment
Conclusion: PZQ is a safe anti-helminthic but hypersensitive
reaction may rarely occur and could be serious. In countries like
Yemen, where there is huge mass treatment especially during
national campaigns against schistosomiasis such rare reactions
could be encounteredmore frequently. Therefore, doctors and ﬁeld
workers during such campaigns should be aware of these reactions
and well prepared to take action.
http://dx.doi.org/10.1016/j.ijid.2014.03.780
Type: Poster Presentation
Final Abstract Number: 45.041
Session: Parasitology and Parasitic Infections
Date: Thursday, April 3, 2014
Time: 12:45-14:15
Room: Ballroom
Malaria case management: Enabling
appropriate use of ACTs
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Background: Several determinants such as unaffordable prices
have limited access to quality assured medicines in most malaria
endemic countries. The Affordable Medicines Facility- malaria
(AmFm), by the Global Fund against Tuberculosis, AIDS andMalaria
(GFTAM)aimedat expandingaccess to themost effective treatment
for malaria, Artemisinin based combinations (ACTs), to save lives
and reduce the presence anduse of less effective treatment options.
Access is not only measured by the availability of the medicines
at the point of use, but the promptness and effectiveness of treat-
ment offered. Improved availability of medicines needs to be
matched with the ability of service providers to handle and appro-
priately diagnose, prescribe and dispense the correct treatment at
the point of care.
In2012 theDivisionofMalaria control introduced the testbefore
you treat policy. Rapid Diagnostic Test Kits (RDTs) were introduced
in the public sector. Capacity building of public sector healthwork-
ers was done before private sector health workers were exposed to
structured training by the division of malaria control.
Methods & Materials: Two sets of cross-sectional data were
collected on a population of 500 private sector health workers
from Nairobi. Pre-test studies done were analyzed for 141 ran-
domly sampledparticipants todetermine their levels of knowledge,
attitudes and practices prior to training.
Results: 85% of the HW had never attended any malaria case
management training. 40% knew the correct frequency of adminis-
tration of AL, 56% did not know the correct loading dose for quinine
and 55% were aware of the second line of treatment. In diagnosis of
malaria 55% could correctly report microscopy laboratory results
while 59% had incorrect perceptions on the utility of RDTs imme-
diately after treatment with AL. 51% did not know how to manage
fever in under ﬁves in accordance with the current guidelines.
Conclusion: Training private sector health workers is an essen-
tial milestone towards achieving increased access to malaria
medicines and appropriate malaria case management. Provision of
low cost rapid diagnostic test kits and further capacity building of
private sector health workers in providing prompt point of care
diagnosis and treatment is required.
http://dx.doi.org/10.1016/j.ijid.2014.03.781
